Mediwelcome extends new-share placement period and long-stop date to 31 August 2026

Bulletin Express07-31

Mediwelcome Healthcare Management & Technology Inc. has signed an extension letter with its placing agent to prolong both the placing period and the long-stop date for its specific-mandate share placement.

The company disclosed that additional time is needed for the placing agent to complete compliance and Know-Your-Client onboarding for several prospective placees. Consequently:

• The expiry of the placing period moves from 31 July 2026 to 31 August 2026. • The long-stop date is likewise deferred to 31 August 2026. • All other terms of the Placing Agreement, as previously amended, remain unchanged.

Completion of the placement remains contingent on satisfaction of the agreement’s existing conditions precedent, and the transaction may or may not proceed. Shareholders and prospective investors are advised to exercise caution when dealing in Mediwelcome shares.

The decision was approved by the board on 31 July 2026 after market close. The board currently comprises four executive directors (Shi Wei, Yang Weimin, Wang Liang, Deng Chengying), one non-executive director (Liu Xia) and three independent non-executive directors (Song Ruilin, David Zheng Wang, Chen Huilin).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1168397995?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 17:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168397995","market":"us","top_or_hot":-1,"title":"Mediwelcome extends new-share placement period and long-stop date to 31 August 2026","media":"Bulletin Express","content":"<p>Mediwelcome Healthcare Management & Technology Inc. has signed an extension letter with its placing agent to prolong both the placing period and the long-stop date for its specific-mandate share placement.</p>\n<p>The company disclosed that additional time is needed for the placing agent to complete compliance and Know-Your-Client onboarding for several prospective placees. Consequently:</p>\n<p>• The expiry of the placing period moves from 31 July 2026 to 31 August 2026.  \n• The long-stop date is likewise deferred to 31 August 2026.  \n• All other terms of the Placing Agreement, as previously amended, remain unchanged.</p>\n<p>Completion of the placement remains contingent on satisfaction of the agreement’s existing conditions precedent, and the transaction may or may not proceed. Shareholders and prospective investors are advised to exercise caution when dealing in Mediwelcome shares.</p>\n<p>The decision was approved by the board on 31 July 2026 after market close. The board currently comprises four executive directors (Shi Wei, Yang Weimin, Wang Liang, Deng Chengying), one non-executive director (Liu Xia) and three independent non-executive directors (Song Ruilin, David Zheng Wang, Chen Huilin).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mediwelcome extends new-share placement period and long-stop date to 31 August 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMediwelcome extends new-share placement period and long-stop date to 31 August 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-31 17:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Mediwelcome Healthcare Management & Technology Inc. has signed an extension letter with its placing agent to prolong both the placing period and the long-stop date for its specific-mandate share placement.</p>\n<p>The company disclosed that additional time is needed for the placing agent to complete compliance and Know-Your-Client onboarding for several prospective placees. Consequently:</p>\n<p>• The expiry of the placing period moves from 31 July 2026 to 31 August 2026.  \n• The long-stop date is likewise deferred to 31 August 2026.  \n• All other terms of the Placing Agreement, as previously amended, remain unchanged.</p>\n<p>Completion of the placement remains contingent on satisfaction of the agreement’s existing conditions precedent, and the transaction may or may not proceed. Shareholders and prospective investors are advised to exercise caution when dealing in Mediwelcome shares.</p>\n<p>The decision was approved by the board on 31 July 2026 after market close. The board currently comprises four executive directors (Shi Wei, Yang Weimin, Wang Liang, Deng Chengying), one non-executive director (Liu Xia) and three independent non-executive directors (Song Ruilin, David Zheng Wang, Chen Huilin).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02159","symbol_name":"麦迪卫康","start_time":0,"source_url":"","article_id":"1168397995","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168397995","pubTimestamp":1785490003,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Mediwelcome Healthcare Management & Technology Inc. has signed an extension letter with its placing agent to prolong both the placing period and the long-stop date for its specific-mandate share...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02159":"麦迪卫康"},"translate_title":"Mediwelcome 将新股配售期及长期停止日延长至 2026 年 8 月 31 日","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02159":1},"content_text":"Mediwelcome Healthcare Management & Technology Inc. has signed an extension letter with its placing agent to prolong both the placing period and the long-stop date for its specific-mandate share placement.\nThe company disclosed that additional time is needed for the placing agent to complete compliance and Know-Your-Client onboarding for several prospective placees. Consequently:\n• The expiry of the placing period moves from 31 July 2026 to 31 August 2026.  \n• The long-stop date is likewise deferred to 31 August 2026.  \n• All other terms of the Placing Agreement, as previously amended, remain unchanged.\nCompletion of the placement remains contingent on satisfaction of the agreement’s existing conditions precedent, and the transaction may or may not proceed. Shareholders and prospective investors are advised to exercise caution when dealing in Mediwelcome shares.\nThe decision was approved by the board on 31 July 2026 after market close. The board currently comprises four executive directors (Shi Wei, Yang Weimin, Wang Liang, Deng Chengying), one non-executive director (Liu Xia) and three independent non-executive directors (Song Ruilin, David Zheng Wang, Chen Huilin).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1168397995","isCrawlerRequest":true}